CClinicalTrials.gg
CompletedNCT01343940dulceUpdated May 18, 2016

Strengthening Families and Reducing Risk Thru Developmental and Legal Collaboration

A Phase 2/3 interventional study of Project dulce and Safety intervention in Parenting, Child Rearing and Child Abuse, sponsored by Boston Medical Center. Completed at 1 site in United States. Per ClinicalTrials.gov, last updated 2016-05-18.

Sponsored by Boston Medical Center · Phase 2/3, Interventional, and Prevention

Phase
Phase 2/3
Study type
Interventional
Enrollment
402
Allocation
Randomized
Sex
All
01

Study summary

Project Dulce is designed to test a new approach to delivering family support, in the context of the primary care medical home. The target population to be served is infants between birth and 6 months old and their families who receive primary care at Boston Medical Center. A dulce family partner will reach infants and families through their routine health care visits during their first six months of life and provide them with support for unmet legal needs, screen infants for developmental problems, screen families for mental health problems, and improve families' knowledge of child development. The control group will receive training on safe sleep and safe transportation for their newborn.

Read the detailed description

Subjects for project dulce will be recruited from parents who receive their newborn child's primary pediatric care from Boston Medical Center's Pediatric Primary Care Clinic. Subjects will be randomized to receive the study intervention or the control.

Project dulce will provide a family partner to parents of infants up to six months of age. The dulce family partner (DFP) will be trained using the Healthy Steps model, an evidence-based approach to support parent understanding of child development, and by Medical Legal Partnership\|Boston to identify legal and social needs that may affect a child's health and development. The dulce family partner will reach infants and families through their routine health care visits during their first six months of life and provide them with support for unmet legal needs, screen infants for developmental problems, screen families for mental health problems, and improve families' knowledge of child development. Families will meet with the DFP at the initial visit, at their subsequent routine healthcare maintenance visits, and during home visits if they wish.

Families in the control group will receive safety education from a trained staff member on safe sleep and safe transportation, at two of their baby's routine well-child visits between 1 and 6 months of age.

Subjects will answer two sets of standard survey questions before and after intervention / control. The infant's electronic medical record will be reviewed up to the first year. This study will test whether the project dulce intervention promotes positive outcomes for children and families, and reduces risks and adverse outcomes. The results of this rigorous program evaluation may be used to support dissemination of project dulce to other primary care sites throughout the country.

PROJECT GOALS 1. Assess whether the highly-structured dulce intervention results in: improved individual and family strengths, reduced risks, and decreased likelihood of child maltreatment. 2. Provide system-level information to assess the costs, resource needs, barriers, and benefits that come from implementing the dulce model within a patient-centered medical home. 3. In addition to the project's research goals, we will collect aggregated Child Protective Service (CPS) community-wide data regarding childhood injury and maltreatment, as is requested by funder.

02

Conditions studied

  • Parenting
  • Child Rearing
  • Child Abuse
  • Child Neglect
  • Child Development

Keywords

  • RCT
  • randomized block repeated measures design
  • efficacy trial
  • high risk population
03

In context

Lead sponsor

Boston Medical Center is the lead sponsor of 314 studies on the registry; 34 are open to participants now.

Of its 34 completed or terminated interventional studies of FDA-regulated products, 28 (82%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • The patient family must include an infant, or infants for families with multiples, born 10 weeks or less prior to recruitment.
  • The newborn(s) must be healthy, having been born without known defects or complications that would require early hospitalization.
  • The infant must have been discharged from hospital within one week.
  • At the time of recruitment, the parent/guardian will have communicated their intent to obtain their newborn infant's primary pediatric care through Boston Medical Center's (BMC's) Primary Pediatric Care Clinic (PPCC).
  • The child's parent/guardian must be able to engage in an informed consent process conducted in English or Spanish.
  • The child's parent/guardian must be able to complete a questionnaire and/or interview (with or without assistance) in English or Spanish.

Exclusion criteria

Exclusion Criteria:

  • The participating parent/guardian is under 18 years of age. As SOC at BMC, mothers under the age of 18 are seen in the The Teen and Tot Program (TTP), a specialized program located within BMC's Adolescent Center.
  • The parent/guardian is unable to participate in required data collection activities in the study languages, even with assistance.
  • The child/family's physician believes that participation in the evaluation would adversely affect the child/family's health or well being or the ongoing delivery of health care services. Decision will be made based on the physician's clinical judgment. All physicians have the opportunity to opt their patients out.
  • The family is already receiving services from another family partner program such as Project RISE, Healthy Steps, etc. through the BMC primary care center.
05

Study design

Phase
Phase 2 / Phase 3
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
402 participants (actual)

Study arms

  • Experimental
    Dulce family partner intervention

    Participating families are assigned to a legal/developmental specialist who joins health care team during well-child visits and home visits. The specialist (a "Dulce family partner") supports parent around child development issues, addresses unmet basic needs (e.g., housing, utilities, food, etc.), and makes referral to existing agencies and services.

    Behavioral: Project dulce

  • Active comparator
    Safety intervention

    Participating family is assigned a safety specialist who will provide the parent with guidance, equipment and instruction to reduce risk of newborn injury during transport (car seat) and while sleeping (Pack-and-Play).

    Behavioral: Safety intervention

Interventions

  • BehavioralProject dulce

    Participating families are assigned to a legal/developmental specialist who joins health care team during well-child visits and home visits. The specialist (a "Dulce family partner") supports parent around child development issues, addresses unmet basic needs (e.g., housing, utilities, food, etc.), and makes referral to existing agencies and services. Specialist meets with family during all routine well-child visits scheduled in primary care between birth and 6 months (1-mo, 2-mo, 4-mo, 6-mo). Parent may meet with specialist before or after scheduled appointment, and may request a home visit. Specialist will be available by phone for consultation.

    Also known as: dulce, dulce family partner

  • BehavioralSafety intervention

    Participating family is assigned a safety specialist. Meeting with the safety specialist will occur before or after a routine well-child visit or at a separately agreed upon time. The specialist will discuss infant injury risks associated with transportation and sleep. The specialist will provide safety equipment (car seat and pack-and-play) and instruct the parent in their proper use.

06

What researchers measure

Primary outcomes

  1. Change from baseline in number of child maltreatment protective factors available to caregiver at 6 months, as measured on the Quality Improvement Center on Early Childhood (QIC) "Caregivers Assessment of Protective Factors"

    Paper-and-pencil questionnaire completed by child's caregiver

    Time frame: t1 (Baseline): at recruitment, prior to intervention; and t2: 6 months later

  2. Change from baseline in number and amount of income supports available to and accessed by caregiver at 6 months, as measured on the Quality Improvement Center on Early Childhood (QIC) "Self-Report Family Inventory" + supplementary questions on $ value

    Paper-and-pencil questionnaire completed by child's caregiver

    Time frame: t1 (Baseline): at recruitment, prior to intervention; and t2: 6 months later

  3. Change from baseline in social capital available to caregiver at 6 months, as measured on the Quality Improvement Center on Early Childhood (QIC) "Social Network Grid"

    Paper-and-pencil questionnaire completed by child's caregiver working with reasearch interviewer. Adapted from: Tracy, EM \& Whittaker, JK (1990). The Social Network Map: Assessing social support in clinical social work practice. Families in Society, 71(8), 461-470.

    Time frame: t1 (Baseline): at recruitment, prior to intervention; and t2: 6 months later

  4. Change from baseline in parental stress at 6 months, as measured by the "Parenting Stress Index (PSI) - long form"

    Paper-and-pencil instrument completed by child's caregiver

    Time frame: t1 (Baseline): at recruitment, prior to intervention; and t2: 6 months later

  5. Change from baseline in parenting and child-rearing attitudes of child's caregiver at 6 months, as measured on the "Adult-Adolescent Parenting Inventory(AAPI-2)"

    Paper-and-pencil instrument completed by child's caregiver; 40 Likert-type items.

    Time frame: t1 (Baseline): at recruitment, prior to intervention; and t2: 6 months later

07

Study locations

1 site
  • Boston Medical Center
    Boston, Massachusetts 02127, United States
08

References and documents

Publications

  • Sege R, Preer G, Morton SJ, Cabral H, Morakinyo O, Lee V, Abreu C, De Vos E, Kaplan-Sanoff M. Medical-Legal Strategies to Improve Infant Health Care: A Randomized Trial. Pediatrics. 2015 Jul;136(1):97-106. doi: 10.1542/peds.2014-2955. Epub 2015 Jun 1. PubMed 26034248 ↗
  • Sege R., Kaplan-Sanoff M., Morton S., Velasco-Hodgson M.C., Preer G., Morakinyo G., De Vos E., Krathen J. Project DULCE: Strengthening families through enhanced primary care. The Journal of Zero to Three. Vol 35(1):10-18, September 2014.

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 18, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01343940
Lead sponsor
Boston Medical Center
Collaborators
Center for the Study of Social Policy
Responsible party
Robert Sege (HRIA Investigator, Boston Medical Center) — Principal investigator
First posted
Apr 28, 2011
Start date
Feb 2011
Primary completion
Dec 2012
Completion
Jun 2013
Last update
May 18, 2016

Study contacts

Robert D Sege, MD, PhD
principal investigator · Boston University
Edward De Vos, EdD
study director · William James College

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2011. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion